Recombinant Human Erythropoietin to Target Cognitive Dysfunction in Bipolar Disorder: A Double-Blind, Randomized, Placebo-Controlled Phase 2 Trial

Miskowiak Kamilla W.; Ehrenreich Hannelore; Christensen Ellen M.; Kessing Lars V.; Vinberg Maj

首页> 外文期刊>The journal of clinical psychiatry >Recombinant Human Erythropoietin to Target Cognitive Dysfunction in Bipolar Disorder: A Double-Blind, Randomized, Placebo-Controlled Phase 2 Trial

【24h】

Recombinant Human Erythropoietin to Target Cognitive Dysfunction in Bipolar Disorder: A Double-Blind, Randomized, Placebo-Controlled Phase 2 Trial

机译：重组人促红细胞生成素对双相情感障碍的目标认知功能障碍：一项双盲，随机，安慰剂对照的2期试验。

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Objective: Available drug treatments for bipolar disorder fail to reverse patients' cognitive deficits. Erythropoietin has neurotrophic actions and aids neurocognitive function. The aim of the study was to investigate the potential of erythropoietin to treat cognitive dysfunction in bipolar disorder.

机译：目的：针对双相情感障碍的可用药物治疗无法逆转患者的认知缺陷。促红细胞生成素具有神经营养作用，并有助于神经认知功能。该研究的目的是研究促红细胞生成素治疗双相情感障碍认知功能障碍的潜力。

著录项

来源
《The journal of clinical psychiatry》 |2014年第12期|共9页
作者
Miskowiak Kamilla W.; Ehrenreich Hannelore; Christensen Ellen M.; Kessing Lars V.; Vinberg Maj;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类精神病学;
关键词

相似文献

外文文献
中文文献
专利

1. Recombinant Human Erythropoietin to Target Cognitive Dysfunction in Bipolar Disorder: A Double-Blind, Randomized, Placebo-Controlled Phase 2 Trial [J] . Ellen M. Christensen, Hannelore Ehrenreich, Kamilla W. Miskowiak, Primary care companion to the journal of clinical psychiatry . 2014,第12期

机译：重组人促红细胞生成素对双相情感障碍的目标认知功能障碍：双盲，随机，安慰剂对照的第二阶段试验。
2. Recombinant Human Erythropoietin to Target Cognitive Dysfunction in Bipolar Disorder: A Double-Blind, Randomized, Placebo-Controlled Phase 2 Trial [J] . Miskowiak Kamilla W., Ehrenreich Hannelore, Christensen Ellen M., The journal of clinical psychiatry . 2014,第12期

机译：重组人促红细胞生成素对双相情感障碍的目标认知功能障碍：一项双盲，随机，安慰剂对照的2期试验。
3. Recombinant Human Erythropoietin to Target Cognitive Dysfunction in Bipolar Disorder: A Double-Blind, Randomized, Placebo-Controlled Phase 2 Trial [J] . Miskowiak Kamilla W., Ehrenreich Hannelore, Christensen Ellen M., The journal of clinical psychiatry . 2014,第12期

机译：重组人促红细胞生成素以双极障碍靶向认知功能障碍：双盲，随机，安慰剂控制的第2阶段试验
4. EFFECT OF TARGETED PULSED ELECTROMAGNETIC FIELD THERAPY ON CANINE POST-OPERATIVE HEMILAMINECTOMY: A DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED CLINICAL TRIAL [C] . ACVS Veterinary Symposium . 2018

机译：靶向脉冲电磁场治疗对犬术后血栓切除术的影响：双盲，随机，安慰剂对照临床试验
5. A Randomized, Double-blind, Placebo-controlled Clinical Trial Evaluating the Effect of Infliximab on General Cognition in a Population of Depressed Individuals with Bipolar Disorder Type I/II [D] . Pan, Zihang. 2018

机译：一项随机，双盲，安慰剂对照的临床试验，评估英夫利昔单抗对I / II型双相情感障碍抑郁症患者总体认知的影响
6. Recombinant Human Erythropoietin for Treating Treatment-Resistant Depression: A Double-Blind Randomized Placebo-Controlled Phase 2 Trial [O] . Kamilla W Miskowiak, Maj Vinberg, Ellen M Christensen, 2014

机译：重组人促红细胞生成素用于治疗抗药性抑郁症：双盲随机安慰剂对照的2期试验
7. Recombinant human erythropoietin for treating treatment-resistant depression: a double-blind, randomized, placebo-controlled phase 2 trial [O] . Miskowiak, K., Vinberg, M., Christensen, E., 2014

机译：用于治疗耐药性抑郁症的重组人促红细胞生成素：一项双盲，随机，安慰剂对照的2期试验

Recombinant Human Erythropoietin to Target Cognitive Dysfunction in Bipolar Disorder: A Double-Blind, Randomized, Placebo-Controlled Phase 2 Trial

摘要

著录项

相似文献

相关主题

期刊订阅